(Total Views: 500)
Posted On: 10/22/2025 11:15:01 AM
Post# of 158140
Jeff wrote: "It’s really not Buffet’s MO to invest in a highly speculative ( by definition, we are) company."
Not only has he invested nearly $200 million in a speculative company, it was in a company that was hoping to treat Alzheimer's.
In 2020, Buffett disclosed a stake of around $192 million in Biogen. Biogen’s future at that time based on aducanumab, a candidate to treat Alzheimer’s, which had previously experienced clinical setbacks. Nasdaq.com:
By 2021, Buffett's company had sold its stake in Biogen for a good-sized profit.
Not only has he invested nearly $200 million in a speculative company, it was in a company that was hoping to treat Alzheimer's.
In 2020, Buffett disclosed a stake of around $192 million in Biogen. Biogen’s future at that time based on aducanumab, a candidate to treat Alzheimer’s, which had previously experienced clinical setbacks. Nasdaq.com:
Quote:
Analysts described this move as one of Buffett’s “riskiest wagers ever” because it went somewhat against his usual “stable, understandable business” style.
By 2021, Buffett's company had sold its stake in Biogen for a good-sized profit.
(5)
(0)
